DOI : 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

Issue 02 · Volume 60 · April 2021 DOI: 10.1055/s-011-50684

Deutsche Gesellschaft für Nuklearmedizin
NuklearMedizin 2021 – digital
, 14.-17.04.2021

Prof. Dr. Michael Schäfers

P60
Deden, L; Boss, M; Aarts, E; Berends, F; de Boer, H; Hazebroek, E; Gotthardt, M: Pancreatic uptake of radiolabeled exendin as a measure of beta cell mass in T2DM before and after bariatric surgery
P61
Boss, M; Kusmartseva, I; Woliner- van der Weg, W; Joosten, L; Brom, M; Behe, M; Tack, C; de Galan, B; Boerman, O; Janssen, M; Atkinson, M; Gotthardt, M: 111In-exendin SPECT imaging suggests presence of residual beta cells in patients with longstanding type 1 diabetes
P63
Eberhardt, N; Steinacker, JP; Hillenbrand, A; Müller-Reinartz, A; Michalski, C; Korf, P; Beer, M; Solbach, C; Kull, T; Beer, AJ: Evaluation der C-11-Methionin-PET/MRT zur Abklärung eines primären Hyperparathyreoidismus